Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma

NCT01460979 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Genital Diseases, Female
Ovarian Diseases
Ovarian Neoplasms
Endometrial Neoplasms

Interventions

DRUG: Temsirolimus

Sponsor

AGO Study Group